.STUDY HIGHLIGHT.06 August 2024.
A large randomized controlled trial with cisgender females highlights the obstacles of fidelity to a daily dental preexposure prophylaxis regiment and also demonstrates that twice-yearly injection of lenacapavir may preserve successful HIV avoidance amounts over 6 months.